SecSonar.com

Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Radiopharm Theranostics Limited (RADX) is a Biotechnology company based in AU with a market capitalization of $5.8M. Revenue grew 1114.3% year-over-year and free cash flow was negative at -$25.4M. This page tracks RADX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

AU · 14 employees · IPO Dec 5, 2024

Valuation

Valuation & price

$4.71 · as of May 17, 2026 · -55.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.13

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.54$5.69$3.84Jul 25Dec 25Jul 26Jul 7, 25$3.84Jul 9, 25$4.17Jul 11, 25$4.14Jul 15, 25$4.22Jul 17, 25$4.27Jul 21, 25$4.31Jul 23, 25$4.63Jul 25, 25$4.71Jul 29, 25$4.81Jul 31, 25$4.70Aug 4, 25$5.03Aug 6, 25$5.05Aug 11, 25$4.71Aug 13, 25$5.38Aug 15, 25$4.89Aug 19, 25$5.02Aug 21, 25$5.65Aug 25, 25$5.60Aug 27, 25$5.64Aug 29, 25$5.49Sep 3, 25$5.50Sep 5, 25$5.75Sep 9, 25$5.62Sep 11, 25$6.25Sep 16, 25$7.00Sep 18, 25$6.79Sep 22, 25$6.05Sep 24, 25$5.95Sep 26, 25$5.75Sep 30, 25$5.52Oct 2, 25$6.06Oct 6, 25$7.09Oct 8, 25$7.54Oct 10, 25$7.03Oct 14, 25$7.11Oct 16, 25$7.11Oct 21, 25$6.06Oct 23, 25$5.56Oct 27, 25$5.28Oct 29, 25$5.01Oct 31, 25$5.26Nov 4, 25$4.95Nov 6, 25$4.53Nov 10, 25$4.96Nov 12, 25$4.68Nov 14, 25$4.40Nov 18, 25$4.30Nov 20, 25$4.49Nov 25, 25$4.67Nov 28, 25$4.56Dec 2, 25$4.23Dec 4, 25$4.59Dec 8, 25$4.39Dec 10, 25$4.28Dec 12, 25$4.26Dec 16, 25$5.99Dec 18, 25$5.49Dec 22, 25$5.24Dec 24, 25$5.49Dec 29, 25$5.37Jan 2, 26$5.16Jan 6, 26$4.80Jan 8, 26$4.79Jan 12, 26$5.15Jan 14, 26$5.20Jan 16, 26$5.14Jan 21, 26$4.88Jan 23, 26$4.93Jan 27, 26$4.92Jan 29, 26$4.98Feb 2, 26$5.15Feb 4, 26$4.90Feb 9, 26$5.12Feb 11, 26$5.07Feb 13, 26$4.90Feb 18, 26$4.89Feb 20, 26$4.98Feb 24, 26$5.05Feb 26, 26$4.98Mar 2, 26$4.95Mar 4, 26$4.82Mar 6, 26$4.99Mar 10, 26$4.98Mar 12, 26$4.89Mar 17, 26$4.86Mar 19, 26$4.72Mar 23, 26$4.64Mar 25, 26$4.33Mar 27, 26$4.25Mar 31, 26$4.30Apr 2, 26$4.40Apr 7, 26$4.35Apr 9, 26$4.67Apr 13, 26$4.49Apr 15, 26$4.65Apr 17, 26$4.58Apr 22, 26$4.64Apr 24, 26$4.51Apr 28, 26$4.38Apr 30, 26$4.27May 4, 26$4.50May 6, 26$4.25May 8, 26$4.00May 12, 26$4.16May 14, 26$4.73May 18, 26$4.75May 20, 26$4.58May 22, 26$4.63May 28, 26$4.62Jun 1, 26$4.68Jun 3, 26$4.49Jun 5, 26$4.32Jun 9, 26$4.25Jun 11, 26$4.39Jun 15, 26$4.45Jun 17, 26$4.42Jun 22, 26$4.31Jun 24, 26$4.14Jun 26, 26$4.02Jul 2, 26$4.37
$3.8452-week range$10.63
Loading valuation history…

Fundamentals

Key fundamentals

$5.8M

Market cap

1114.3%

Revenue growth (YoY)

1.1%

Gross margin

-$25.4M

Free cash flow (USD)

-$29.1M

Net debt

Net cash position

438.5%

Share dilution

2/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2022 → 2025

FY 2022$8.8KFY 2023$292.4KFY 2024$299.2KFY 2025$3.6M
$8.8K$3.6M

Free cash flow by year

2022 → 2025

FY 2022$-38.3MFY 2023$-24.7MFY 2024$-23.0MFY 2025$-36.6M
-$38.3M-$36.6M

Gross margin by year

2022 → 2025

FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 20251.1%
100.0%1.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Apr 23, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingNotification of SecuritiesJun 30, 2026Filing
  • 6-K filingNotification of Cessation of SecuritiesJun 3, 2026Filing
  • 6-K filingFinancial Services and Company Secretary ChangesMay 1, 2026Filing
  • Annual reportAnnual Report FiledApr 23, 2026Filing
  • 6-K filingInitial Findings from Phase 1 TrialApr 20, 2026Filing
  • 6-K filingClinical Trial Enrollment CompletedApr 16, 2026Filing
  • 6-K filingClinical Trial UpdateApr 8, 2026Filing
  • 6-K filingClinical Supply AgreementApr 7, 2026Filing

Questions

Frequently asked questions

What is Radiopharm Theranostics Limited's market cap?

Radiopharm Theranostics Limited (RADX) has a market capitalization of $5.8M.

What is RADX's P/E ratio?

A meaningful P/E ratio is not available for RADX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is RADX's price-to-book (P/B) ratio?

RADX trades at 0.13 times book value per share.

Are insiders buying RADX stock?

SEC Form 4 filings show no open-market insider buys at Radiopharm Theranostics Limited in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CELZ

Creative Medical Technology Holdings, Inc.

$5.9M

XBIO

Xenetic Biosciences, Inc.

$5.9M

XTLB

XTL Biopharmaceuticals Ltd.

$5.7M

NITO

N2OFF, Inc.

$5.5M

EVGN

Evogene Ltd.

$6.1M

MLEC

Moolec Science S.A.

$5.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.